参考文献/References:
[1] Fülster S,Tacke M,Sandek A,et al. Muscle wasting in patients with chronic heart failure:results from the studies investigating co-morbidities aggravating heart failure(SICA-HF)[J]. Eur Heart J,2013(7):512-519.
[2] 王晓萍,周婵娟,谭玲玲,等. 慢性心力衰竭合并肌少症的研究进展[J]. 中华老年多器官疾病杂志,2022,21(7):552-556.
[3] Poehlman ET,Scheffers J,Gottlieb SS,et al. Increased resting metabolic rate in patients with congestive heart failure[J]. Ann Intern Med,1994,121(11):860-862.
[4] Hughes CM,Mcgartland C,Cran G,et al. 680 Evidence of reduced food intake and poorer nutritional intake in chronic heart failure patients[J]. Eur J Heart Fail Suppl,2015,6(1):148-149.
[5] ?lhan B,Bahat G,Erdo?an T,et al. Anorexia is independently associated with decreased muscle mass and strength in community dwelling older adults[J]. J Nutr Health Aging,2019,23(2):202-206.
[6] Ardahanli I,Elik M. Nutrition in heart failure[J]. S ryahwa Publications,2018,2(2):41-42.
[7] Boman K. Digitalis intoxication in geriatric in-patients. A prospective clinical study of the value of serum digitalis concentration measurement[J]. Acta Med Scand,2010,214(5):345-351.
[8] Liu JC,Dong SS,Shen H,et al. Multi-omics research in sarcopenia:current progress and future prospects[J]. Ageing Res Rev,2022,76:101576.
[9] Drummond MJ,Dickinson JM,Fry CS,et al. Bed rest impairs skeletal muscle amino acid transporter expression,mTORC1 signaling,and protein synthesis in response to essential amino acids in older adults[J]. Am J Physiol Endocrinol Metab,2012,302(9):E1113.
[10] Coker RH,Hays NP,Williams RH,et al. Bed rest worsens impairments in fat and glucose metabolism in older,overweight adults[J]. J Gerontol A Biol Sci Med Sci,2014,69(3):363-370.
[11] Dos Santos MR,Saitoh M,Ebner N,et al. Sarcopenia and endothelial function in patients with chronic heart failure:results from the studies investigating comorbidities aggravating heart failure(SICA-HF)[J]. J Am Med Dir Assoc,2017,18(3):240-245.
[12] Rossi FE,Lira FS,Silva BSA,et al. Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly[J]. Aging Clin Exp Res,2019,31(5):629-635.
[13] Chun SW,Shin SK. Effects of changes in frequency of low intensity aerobic and resistance exercise on inflammation factors in sarcopenic obesity elderly women[J]. Korean J Sport Studies,2018.DOI:10.23949/kjpe.2018.05.57.3.23.
[14] Onder G,Liperoti R,Russo A,et al. Body mass index,free insulin-like growth factor I,and physical function among older adults:results from the ilSIRENTE study[J]. Am J Physiol Endocrinol Metab,2006,291(4):E829-E834.
[15] Consitt LA,Saneda A,Saxena G,et al. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass[J]. Skelet Muscle,2017,7(1):17.
[16] Doss HM,Kim JY,Kim KS. Taurine supplementation inhibits the expression of atrogin-1 and MURF-1,protein degradation marker genes,in skeletal muscle of C26-induced cachexia mouse model[J]. Adv Exp Med Biol,2022,1370:129-136.
[17] Yin J,Lu X,Qian Z,et al. New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure[J]. Theranostics,2019,9(14):4019-4029.
[18] Groennebaek TS,Sieljacks P,Nielsen R,et al. Effect of blood flow restricted resistance exercise and remote ischemic conditioning on functional capacity and myocellular adaptations in patients with heart failure[J]. Circ Heart Fail,12(12):e006427.
[19] Fisher S,Smart NA,Pearson MJ. Resistance training in heart failure patients:a systematic review and meta-analysis[J]. Heart Fail R ev,2022,27(5):1665-1682.
[20] Selig SE,Carey MF,Menzies DG,et al. Moderate-intensity resistance exercise training in patients with chronic heart failure improves strength,endurance,heart rate variability,and forearm blood flow[J]. J Card Fail,2004,10(1):21-30.
相似文献/References:
[1]戴玫,付珞,胡建英,等.慢性心力衰竭患者应用高强度间歇性有氧训练研究进展[J].心血管病学进展,2016,(3):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
DAI Mei,FU Luo,HU Jianying,et al.Advances in Research on High-intensity Interval Training in Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2016,(11):271.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.014]
[2]张培,综述,刘剑,等.慢性心力衰竭并发肌少症的研究进展[J].心血管病学进展,2016,(3):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
ZHANG Pei,LIU Jian.Research Progress in Chronic Heart Failure-induced Sarcopenia[J].Advances in Cardiovascular Diseases,2016,(11):275.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.015]
[3]田晶,张青,张岩波,等.慢性心力衰竭结局评价指标研究进展[J].心血管病学进展,2019,(6):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
TIAN Jing,ZHANG qing,ZHANG Yanbo,et al.Outcome Indicators for Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2019,(11):931.[doi:10.16806/j.cnki.issn.1004-3934.2019.0.023]
[4]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J].心血管病学进展,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
HU Wei,SU Fangju,ZHANG Weize.Application of Left Ventricular Quadrupole in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2020,(11):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
[5]郭岐龙 芦颜美 张玲 张疆华 邢强 祖克拉·吐尔洪 李耀东 周贤惠 汤宝鹏.新疆地区老年慢性心力衰竭住院患者的病因、合并症及药物治疗的多中心回顾性分析[J].心血管病学进展,2020,(4):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
GUO Qilong,LU Yanmei,ZHANG Ling,et al.Etiology, Comorbidity and Drug Treatment of Elderly Inpatients with Chronic Heart Failure in Xinjiang: A Multi-center Retrospective Study[J].Advances in Cardiovascular Diseases,2020,(11):414.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.021]
[6]毛玉琳 何胜虎.2型糖尿病和慢性心力衰竭[J].心血管病学进展,2020,(5):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
MAO Yulin,HE Shenghu.Type 2 Diabetes Mellitus and Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(11):491.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.012]
[7]郭曦滢,孙煌,樊朝美,等.非奈利酮治疗慢性心力衰竭的研究进展[J].心血管病学进展,2020,(10):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
GUO XiyingSUN HuangFAN ChaomeiZHANG Jian.Finerenone in the Treatment of Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2020,(11):1021.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.006]
[8]吴燕婷 李萍 吴寒.慢性心力衰竭再住院率研究进展[J].心血管病学进展,2021,(8):691.[doi:10.16806/j.cnki.issn.1004-3934-2021.08.005]
WU Yanting,LI Ping,WU Han.Rehospitalization Rate of Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2021,(11):691.[doi:10.16806/j.cnki.issn.1004-3934-2021.08.005]
[9]陈晓梅 陈巧玮 曾纪娟 张庆.可穿戴设备在慢性心力衰竭患者管理中的应用进展[J].心血管病学进展,2023,(3):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
CHEN Xiaomei,CHEN Qiaowei,ZENG Jijuan,et al.Application of Wearable Devices in Management of Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(11):233.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.010]
[10]李彤 呼海娟 崔炜.慢性心力衰竭患者脑钠肽抵抗机制的研究进展[J].心血管病学进展,2023,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
LI Tong,HU Haijuan,CUI Wei.Mechanism of Brain Natriuretic Peptide Tolerance in Patients with Chronic Heart Failure[J].Advances in Cardiovascular Diseases,2023,(11):238.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.011]
[11]高亮 芦颜美.慢性心力衰竭并发肌少症和恶病质的诊治进展[J].心血管病学进展,2023,(7):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]
GAO Liang,LU Yanmei.Diagnosis and Treatment of Chronic Heart Failure Complicated with Sarcopenia and Cachexia[J].Advances in Cardiovascular Diseases,2023,(11):598.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.006]